Aim Adipocyte-derived mesenchymal stem cells (AMSCs) have recently been studied as a potential new approach for regeneration treatment of heart failure and ischemic myocardium. However, donor’s age is thought to affect the ability of AMSC cells to differentiate into cardiomyocytes. This study aimed to analyse the association between donor’s age with the expression of cardiomyocyte marker cardiac isoform of Troponin-T (cTnT) quantity on AMSCs. Methods Subcutaneous adipose tissue was taken from donors of 3 different age groups (30-40, 41-50, and >50 years old), and then processed into AMSC cells by insert culture. AMSC cell phenotype was identified by assessing the quantity of mesenchymal markers expression (CD34, CD45, CD90, CD105) using indirect immunofluorescence technique. Afterwards, cTnT expression, a marker for cardiomyocyte differentiation from AMSC cells, was evaluated under the fluorescent microscope. The comparison was done between the 3 different age groups. Results The comparative test and post hoc analysis showed that there were differences in the expression of CD34, CD45, CD90, CD105, and cTnT between the three age groups (all p<0.05). Furthermore, there were strong negative correlations between age and CD34, CD90, CD105 and cTnT (r= -0.844, -0.914, -0.899, and -0.738, respectively), while the correlation was positive between age and CD45 (r=0.899). Conclusion Expression quantity of mesenchymal markers and cardiomyocyte markers from AMSC cells were affected by the donor’s age. The higher the donor age group, the lower the expression quantity of mesenchymal markers (except CD45) and cTnT.
Elgendy IY, Mahtta D, Pepine CJ. Medical therapy for heart failure caused by ischemic heart disease. Vol. 124, Circ Res. 2019. p. 1520–35.
2.
Chagastelles PC, Nardi NB. Biology of stem cells: an overview. Vol. 1, Kidney Int Suppl. 2011. p. 63–7.
3.
Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Vol. 96, Adv Drug Deliv Rev. 2016. p. 3–17.
4.
Sampogna G, Guraya SY, Forgione A. Regenerative medicine: historical roots and potential strategies in modern medicine. Vol. 3, J Microsc Ultrastruct. 2015. p. 101–7.
5.
Tsuji W, Rubin JP, Marra KG. Adipose-derived stem cells: implications in tissue regeneration. Vol. 6, World J Stem Cells. 2014. p. 312–21.
6.
Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: a review of the literature and future directions. Vol. 14, Regen Ther. 2020. p. 136–53.
7.
Yang YK, Ogando CR, Wang See C, Chang TY, Barabino GA. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Vol. 9, Stem Cell Res Ther. 2018.
8.
Guo X, Bai Y, Zhang L, Zhang B, Zagidullin N, Carvalho K, et al. Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications. Vol. 9, Stem Cell Res Ther. 2018.
9.
Shi S, Wu X, Wang X, Hao W, Miao H, Zhen L, et al. Differentiation of bone marrow mesenchymal stem cells to cardiomyocyte-like cells is regulated by the combined low dose treatment of transforming growth factor-beta1 and 5-azacytidine. Vol. 2016, Stem Cells Int. 2016.
10.
Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Vol. 94, Circ Res. 2004. p. 223–9.
11.
Narbonne P. The effect of age on stem cell function and utility for therapy. Vol. 10, Cell Med. 2018.
12.
Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Vol. 102, Circ Res. 2008. p. 1319–30.
13.
Derman BA, Kordas K, Ridgeway J, Chow S, Dale W, Lee SM, et al. Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantationin older adults. Vol. 3, Blood Adv. 2019. p. 3488–98.
14.
Lee J, Lee KS, Kim CL, Byeon JS, Gu NY, Cho IS, et al. Effect of donor age on the proliferation and multipotency of canine adipose-derived mesenchymal stem cells. Vol. 18, J Vet Sci. 2017. p. 141–8.
15.
Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. Vol. 12, J Transl Med. 2014.
16.
Ihwah A, Deoranto P, Wijana S, Dewi IA. Comparative study between Federer and Gomez method for number of replication in complete randomized design using simulation: study of Areca Palm (Areca catechu) as organic waste for producing handicraft paper. Vol. 131, IOP Conference Series: Earth and Environmental Science. 2018.
17.
Jumabay M, Bostrom KI. Dedifferentiated fat cells: a cell source for regenerative medicine. Vol. 7, World J Stem Cells. 2015. p. 1202–14.
18.
Li Y, Wu Q, Wang Y, Li L, Bu H, Bao J. Senescence of mesenchymal stem cells (Review. Vol. 39, Int J Mol Med. 2017. p. 775–82.
19.
Liu M, Lei H, Dong P, Fu X, Yang Z, Yang Y, et al. Adipose-derived mesenchymal stem cells from the elderly exhibit decreased migration and differentiation abilities with senescent properties. Vol. 26, Cell Transplant. 2017. p. 1505–19.
20.
Dufrane D. Impact of age on human adipose stem cells for bone tissue engineering. Vol. 26, Cell Transplant. 2017. p. 1496–504.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.